Cytovia
Therapeutics is a Massachusetts-based preclinical-stage pharmaceutical company that develops natural killer cell therapeutics for cancer patients... Read moreCytovia
Therapeutics is a Massachusetts-based preclinical-stage pharmaceutical company that develops natural killer cell therapeutics for cancer patients... Read more
2019
PrivateIndependent Company
News
Jan 20, 2023
BioSpace
Cytovia: Cellectis Amends $20 Million Convertible Note Under Collaboration Agreement with its Partner Cytovia Therapeutics
Jan 20, 2023
Yahoo
Cytovia: Cellectis Amends $20 Million Convertible Note Under Collaboration Agreement with its Partner Cytovia Therapeutics
Dec 09, 2022
Markets Insider
Cytovia: Cytovia Therapeutics Presents New Data on CD38-Targeted Flex-NK Bispecific Antibody at 2022 American Society of Hematology Annual Meeting
Nov 07, 2022
Markets Insider
Cytovia: Cytovia Therapeutics Presents New Data on TALEN Gene-Edited iNK Cells and GPC3-Targeted Flex-NK Bispecific Antibodies at 2022 SITC Annual Meeting
Sep 06, 2022
Markets Insider
Cytovia: Cytovia Therapeutics Mourns the Passing of Cancer Immunotherapy Industry Leader and COO Dr. Olivier Jean-Marie Goudard
Jul 06, 2022
The Business Journals: Tampa Bay
Cytovia: St. Pete SPAC calls off merger agreement
Jul 01, 2022
Markets Insider
Cytovia: Isleworth Healthcare Acquisition, Cytovia terminate merger pact (NASDAQ:ISLE)
Jun 10, 2022
FirstWord Pharma
Cytovia: Cytovia Therapeutics presents antitumor activity of its CD38-Targeting Flex-NK Cell Engager antibody at EHA 2022 Congress
May 18, 2022
FirstWord Pharma
Cytovia: Cytovia Therapeutics to Present In Vivo Multiple Myeloma Data of its CD38-Targeting Flex-NK Cell Engager at EHA 2022 Congress
May 06, 2022
FirstWord Pharma
Cytovia: Cytovia Therapeutics to Present at AACR Special Conference on Advances in the Pathogenesis and Molecular Therapies of Liver Cancer